Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will present a company overview at the Leerink Partners Global Healthcare Conference on Wednesday,
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
TEL AVIV, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in March as follows:
Eric Easom, Co-Founder, Chairman, President and CEO, will provide a corporate overview on Wednesday, March 12, 2025 at 2:20 pm ET, and members of management will be available for 1X1 meetings. A ...
announced that its management will present at the Leerink Partners 2025 Global Healthcare Conference on March 10, 2025, in Miami, FL, at 4:20 PM ET. During the conference, they will also ...
today announced that members of its senior leadership team will participate in a fireside chat at the Leerink Partners ...
We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. How we use your information depends on the product and service ...
Shukla, M.D., M.S., President and Chief Executive Officer, will present at the Leerink Partners Global Healthcare Conference, which is scheduled to take place March 9 – 12, 2025, in Miami ...
today announced that its management team will present at the Leerink Partners 2025 Global Healthcare Conference at 4:20pm ET (1:20pm PT) on Monday, January 10, 2025, in Miami, FL. Management ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback